The pharma messaging space is evolving at a fast pace, says Jain
Doceree of New Jersey, with offices in London and New Delhi, says the US$35 million Series B round is to accelerate product development, augment technologies, scale global expansion and expand team.
The leading global network of physician-only platforms for programmatic messaging platform said Creaegis, the leading digital and technology investment firm, led the round B with participation from existing investors, Eight Roads Ventures and F-Prime Capital.
“We are growing massively and have competitive edge. We are thrilled about the future as we continue to expand and touch new horizons in the space,” said Harshit Jain MD, Founder & Global CEO, Doceree.
“The pharma messaging space is evolving at a fast pace and our solutions are aligned to meet the immediate requirements of the life sciences industry. The investment speaks volumes about the value we are creating in the space
“We are pioneering HCP messaging solutions that are first to market. It is incredible to watch our innovative products disrupt the space and drive adoption of programmatic technology in the life-sciences industry, not just in evolved markets like the US, but also elsewhere in the same vein.
“We have been able to simplify HCP engagement globally with our unique AI-enabled proprietary technology and offer quality end-to-end HCP-targeting solutions that have helped our clients succeed with profitable growth,” Jain said on 28 Sept 2023.
Doceree has grown more than 100% in the last one year with monthly revenue rising five folds between the Series A funding in April 2022 and now. The company has introduced category-first innovations on the demand and supply sides, including Doceree Enterprise, an HCP-focussed global Demand Side Platform (DSP), and Doceree Provider that empowers HCPs to improve health outcomes of their patients.
Its HCP marketing ecosystem consists of custom-built solutions that equip life science marketers to engage with physicians at opportune moments with contextual messaging and evaluate campaign performances to improve script lift.
Founded in 2019, Doceree empowers pharmaceutical and life-sciences companies and healthcare media agencies with solutions that seamlessly reach HCPs on their networks and within their digital workflows, to achieve better patient health outcomes.
The company, with its largest global network of HCP-only digital platforms, has made rapid strides in HCP communications through its programmatic messaging capabilities, to help clients across the globe maximize performance of their physician engagement initiatives. Fiinews.com
